Literature DB >> 6662165

Pharmacokinetics of metapramine (19560 RP) in man after infusion and intravenous injection.

Y C Sumirtapura, Y Leroux, A R Komar, J P Cano, J Gaillot.   

Abstract

The time course of the plasma level metapramine following infusion at three different rates (1.18, 2.36 and 4.71 mg/h) has been studied in six healthy volunteers. The correlation coefficient of drug concentration and rate of infusion was 0.974 (alpha less than 0.001, n = 18). Plasma clearance, estimated from the steady-state level, varied from 68 to 1071/h. 3 subjects also received 35 mg of drug by i.v. bolus injection and plasma concentrations were determined at set times for up to 24 h. The plasma level of metapramine decreased tri-exponentially, with a terminal half-life of about 7.4 h. The plasma clearance after i.v. injection was in good agreement with that observed during the infusion study. Apparent volumes of distribution ranged from 41.9 to 90.31.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6662165     DOI: 10.1007/bf00542357

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  [Therapeutic trial of antidepressive agent 19560-RP metapramine].

Authors:  L F Gayral; J J Oules; M M Escande; E G Goldberger
Journal:  Encephale       Date:  1978       Impact factor: 1.291

Review 2.  Drug kinetics and hepatic blood flow.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

3.  Rapidly achieved plasma concentration plateaus, with observations on theophylline kinetics.

Authors:  P A Mitenko; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

4.  Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1970-01       Impact factor: 3.534

5.  [Metapramine: antidepressant and psycho-stimulant].

Authors:  M Bonierbale; H Dufour; J C Scotto; J M Sutter
Journal:  Encephale       Date:  1976       Impact factor: 1.291

6.  [Biotransformation of metapramine in three animal species (dog, rabbit, rat) and in man].

Authors:  B Decouvelaere; B Terlain; A Bieder
Journal:  Therapie       Date:  1982 May-Jun       Impact factor: 2.070

7.  [Comparative study of the pharmacological and clinical effects of clorimipramine and metaprimine (19560 R.P.)].

Authors:  P Dick
Journal:  Encephale       Date:  1978       Impact factor: 1.291

8.  High-performance liquid chromatographic method for the determination of plasma and urine metapramine after dansylation.

Authors:  J P Sommadossi; M Lemar; J Necciari; Y Sumirtapura; J P Cano; J Gaillot
Journal:  J Chromatogr       Date:  1982-03-12
  8 in total
  2 in total

1.  Kinetics of metapramine and its demethylated metabolites after single and chronic oral administration in man.

Authors:  A M Bougerolle; J L Chabard; G Dordain; A Frydman; J Gaillot; J J Piron; J Petit; J A Berger
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Apr-Jun       Impact factor: 2.441

2.  Plasma and brain pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites after acute intraperitoneal injection in mice.

Authors:  F Coudore; J Fialip; A Eschalier; J Lavarenne
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.